Implantation of XEN‑45 for Treatment of Refractory Secondary Glaucoma - Top-Institutions - MDSpire

Implantation of XEN‑45 for Treatment of Refractory Secondary Glaucoma

  • By

  • Kun Lv

  • Zhiqiao Liang

  • Kuankuan Wu

  • Yao Ma

  • Kangyi Yang

  • Wenbo Liu

  • Huijuan Wu

  • November 14, 2025

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Glaucoma Surgery
    • MIGS

  • #2

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Glaucoma
    • Clinical Research

  • #3

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, PA

    Key Differentiators

    • Ophthalmology
    • Glaucoma Surgery

  • #4

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, N/A

    Key Differentiators

    • Ophthalmology
    • Glaucoma

  • #5

    Duke University Eye Center
    Duke University Eye Center

    Durham, NC

    Key Differentiators

    • Ophthalmology
    • Glaucoma Surgery

Original Source(s)

Implantation of XEN‑45 for Treatment of Refractory Secondary Glaucoma

  • by Kun Lv, Zhiqiao Liang, Kuankuan Wu, Yao Ma, Kangyi Yang, Wenbo Liu, Huijuan Wu

  • November 14, 2025

Related Content

OCT Shows Slowing of Structural Glaucoma Progression After SLT 

“Results suggest that SLT may help slow progression of glaucomatous damage over time,” said Raeesah Ahsan, BA, in her presentation.  

Emerging Therapeutic Targets in Noninfectious Uveitis and Scleritis

Thirty Years Together in a Career Defined by Change

Progress begins when we accept that the only certainty is uncertainty.